July 28, 2025 Scantox Earns EcoVadis Bronze Medal for Sustainability Excellence June 27, 2025 Scantox Receives Full AAALAC Accreditation—Reinforcing Our Commitment to Animal Welfare and Scientific Integrity April 28, 2025 Annual Report 2024 released November 4, 2024 ACT 2024: Stay Ahead With Scantox’s Expanded Toxicology Services September 29, 2024 Scantox Showcases Cell and Gene Therapy Capabilities at ESGCT 2024 September 18, 2024 Discover Scantox’s Innovative Preclinical Model Systems at Neuroscience 2024 September 9, 2024 Scantox Group acquires Gentronix, a world leader in genetic toxicology August 22, 2024 Maximize Partnership Opportunities at Eurotox and NLS Days June 3, 2024 Finding Solutions for Neuroinflammation – Scantox at CNS Therapeutics Xchange 2024 May 14, 2024 Neuro4D: A Focused Meeting of Neuroscience Experts May 6, 2024 Minipigs in Focus: Join Scantox at the 16th MRF in Amsterdam April 24, 2024 Annual Report 2023 released April 2, 2024 Scantox closes the acquisition of QPS Neuropharmacology – now Scantox Neuro February 20, 2024 Visit Scantox at SOT in Salt Lake City: Discover Expanded Service Offerings and Collaborative Atmosphere November 30, 2023 Scantox acquires QPS Austria’s Neuropharmacology Division November 20, 2023 Scantox continues its growth journey with the acquisition of Solural Pharma August 31, 2023 Scantox acquires Q&Q – strengthening its offering within bioanalytical services July 7, 2023 Scantox appoints Andy Brown as Group Chief Commercial Officer June 14, 2023 Exclusive genOway distributors in the Nordics April 26, 2023 Scantox Certified as 2023 Great Place to Work January 27, 2023 Scantox Wins ’Company of the Year 2022’ Award November 21, 2022 Danish Award Nomination October 6, 2022 Humanized Minipigs August 31, 2022 Scantox Acquires Timeline Bioresearch and Adlego Biomedical
